[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

Bibliographic Details
Main Authors: Lorenzo Pradelli, Paolo Ascierto
Format: Article
Language:English
Published: SEEd Medical Publishers 2017-09-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1329